Loading...
HomeServicesStudy Close-Out

StudyClose-Out

Meticulous closure of your clinical trials, including comprehensive documentation, data validation, and final reporting. We manage study close-out as a critical operational phase, ensuring full regulatory compliance, data integrity, and readiness for post-study activities.

Our close-out activities include

Final Data Validation and Reconciliation

Thorough review and resolution of all data discrepancies, guaranteeing the reliability and integrity of final datasets for regulatory submission.

Database Lock

Coordination and execution of database lock procedures, ensuring all clinical data is complete, validated, and locked according to predefined quality criteria and regulatory standards.

Final Reporting and Submission Support

Preparation, coordination, and quality review of final study deliverables, including the Clinical Study Report (CSR) and supporting regulatory documentation.

Essential Document Archiving

Complete collection, verification, and secure archiving of trial documentation in full compliance with GCP and applicable regulatory requirements.

Budget Reconciliation

Comprehensive financial review and final reconciliation of study budgets, ensuring transparency, closure of site payments, and alignment with contractual obligations.

At GALSER, study close-out is handled with the same rigor and dedication as study start-up - delivering a complete, compliant, and publication-ready outcome.

FAQ

Business professional

Feedback from our clients

We were impressed by GALSER’s strong relationships with the study sites and their ability to keep things moving despite the usual challenges. It really helped us stay on track
Big Pharma​
Head of Global Clinical Development

01

/05

Your level of detail and expertise really stand out. It’s been a real pleasure working together!
Start-Up​
CMO

02

/05

The GALSER team guided us through the Swiss regulatory process with clear advice and great responsiveness. Their support made the entire submission much easier than we anticipated.
Mid-Size Company​
Director Clinical Operations Europe

03

/05

A remarkable project leader who managed to deliver a high-quality protocol in a very short time
Swiss University Hospital
Principal Investigator - Initiated Investigator Trial

04

/05

GALSER team has shown a great mix of professionalism, flexibility/adaptability and profound knowledge of the human research landscape in Switzerland
Big Pharma​
Medical Affairs Associate

05

/05

Loading...